Physician profile
Angela Jackson
NPI 1003018136
$3,193.03
in general payments reported to CMS, 2019-2025
36 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $990 · 2023: $728 · 2024: $579 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.16 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $410.33 | 2021-2025 | |
| Pfizer INC. | $269.97 | 2021-2025 | |
| Novo Nordisk INC | $255.98 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $216.64 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Abbott Laboratories | $201.79 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astellas Pharma US INC | $201.05 | 2021-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.77 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $187.05 | 2021-2025 | Breztri, Farxiga |
| Radius Health, INC. | $122.16 | 2022-2025 | Tymlos |
| Amgen INC. | $104.67 | 2021-2024 | Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.12 | 2021-2024 | Trulance, Xifaxan |
| Lundbeck LLC | $96.37 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $82.53 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $73.06 | 2023-2024 | Auvelity |
| Glaxosmithkline, LLC. | $70.01 | 2021-2024 | Trelegy Ellipta |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $59.54 | 2022-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $50.90 | 2022 | |
| Merck Sharp & Dohme LLC | $43.47 | 2022 | |
| Currax Pharmaceuticals LLC | $42.97 | 2023-2025 | Nexletol, Contrave |
| Boston Scientific Corporation | $42.26 | 2022 | |
| Sumitomo Pharma America, INC. | $42.21 | 2023-2025 | Gemtesa |
| Bausch Health US, LLC | $38.19 | 2025 | Wellbutrin, Aplenzin |
| Biohaven Pharmaceutical Holding Company LTD. | $37.33 | 2022 | |
| Sunovion Pharmaceuticals INC. | $32.27 | 2022 | |
| Phathom Pharmaceuticals, INC. | $28.85 | 2024 | Voquezna |
| Paratek Pharmaceuticals, INC. | $20.91 | 2023 | Nuzyra |
| Antares Pharma, INC. | $19.85 | 2022 | |
| Halozyme INC | $18.60 | 2023 | |
| Mylan Specialty L.P. | $17.96 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $17.29 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.31 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.64 | 2023 | Quviviq |
| Amarin Pharma, INC. | $15.14 | 2021 | |
| Dexcom, INC. | $14.94 | 2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $13.66 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.